Medicure Inc. (MPH.V)
| Previous Close | 0.9300 |
| Open | 0.9300 |
| Bid | 0.9900 x 0 |
| Ask | 1.1000 x 0 |
| Day's Range | 1.0000 - 1.0000 |
| 52 Week Range | 0.8200 - 2.0100 |
| Volume | |
| Avg. Volume | 1,447 |
| Market Cap | 9.534M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6100 |
| Earnings Date | Aug. 09, 2021 - Aug. 13, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Algernon Pharmaceuticals Announces New Chief Financial Officer
VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has appointed Mr. James Kinley as the Company’s Chief Financial Officer (“CFO”), effective December 1, 2021. Mr. Kinley will report to Algernon’s Chief Executive Officer (“CEO”) Mr. Christopher J. Moreau. Mr. Kinley is a Certified Professional Account
- CNW Group
Medicure Reports Financial Results for Quarter Ended September 30, 2021
Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2021.
- CNW Group
Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans
Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, is pleased to announce that it is planning to launch a national direct-to-consumer E-Commerce pharmacy platform through its subsidiary, Marley Drug™ pharmacy, before the end of 2021.
